← Main Index Directory
GHK-Cu Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Topical application formats isolate actions directly to skin remodeling metrics. Subcutaneous tracks systemic aging variables.
Biological Half-Life Metric: Very brief plasma persistence (~1 hour).
Recommended In-Vitro Dosing Architecture
Subcutaneous injection standard is 1mg to 2mg daily. Topical formulations typically demand 1% to 3% serum concentrations.
Standard Target Observation Timelines
Continuous application metrics map structural adjustments over 30 to 60-day testing blocks.